22763-69-5 Usage
Description
1-(2-Pyrrolidinoethyl)piperazine, also known as 1-(2-(1-Pyrrolidinyl)ethyl)piperazine, is an organic compound that serves as a crucial intermediate in the synthesis of various pharmaceuticals, agrochemicals, and dyestuff. It is a colorless liquid with unique chemical properties that make it valuable in the development of different products.
Uses
Used in Pharmaceutical Industry:
1-(2-Pyrrolidinoethyl)piperazine is used as an intermediate for the synthesis of various pharmaceutical compounds. Its unique chemical structure allows for the creation of a wide range of medications, making it an essential component in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical industry, 1-(2-Pyrrolidinoethyl)piperazine is used as a key raw material in the production of various agrochemical products. Its properties contribute to the effectiveness of these products, enhancing their performance in agricultural applications.
Used in Dye Industry:
1-(2-Pyrrolidinoethyl)piperazine is also utilized as a vital component in the dye industry. Its chemical properties make it suitable for the creation of a diverse range of dyes, contributing to the vibrancy and variety of colors available in the market.
Check Digit Verification of cas no
The CAS Registry Mumber 22763-69-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,7,6 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 22763-69:
(7*2)+(6*2)+(5*7)+(4*6)+(3*3)+(2*6)+(1*9)=115
115 % 10 = 5
So 22763-69-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H21N3/c1-2-6-12(5-1)9-10-13-7-3-11-4-8-13/h11H,1-10H2/p+3
22763-69-5Relevant articles and documents
3-PHENYLSULPHONYL-QUINOLINE DERIVATIVES AS AGENTS FOR TREATING PATHOGENIC BLOOD VESSELS DISORDERS
-
Paragraph 0345, (2021/04/23)
The disclosure provides compounds, and compositions, including pharmaceutical compositions, kits that include the compounds, and methods of using (or administering) and making the compounds. The disclosure further provides compounds or compositions thereof for use in a method of modulating PLXDC1 (TEM7) and/or PLXDC2 or killing pathogenic blood vessles. The disclosure further provides compounds or compositions thereof for use in a method of treating a disease, disorder, or condition that is mediated, at least in part, by PEDF receptors or by angiogenesis.
Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents
Liang, Yu-Kun,Yue, Zhi-Zhou,Li, Jia-Xin,Tan, Cun,Miao, Ze-Hong,Tan, Wen-Fu,Yang, Chun-Hao
, p. 505 - 515 (2014/08/05)
Two series of novel 2-substituted 5,7-dihydroxyanthra[2,1-d]thiazole-6,11- dione derivatives from natural rhein were designed, synthesized and evaluated for their antitumour activities against human cancer cell lines A549 and HeLa in vitro.
